Premenopausal Breast Cancer
Showing 1 - 25 of >10,000
Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for
Recruiting
- Breast Cancer
- Dalcelli、Exemestane、Gosserine
- Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection
-
Tianjin, Tianjin, ChinaJie Ge
Aug 20, 2023
Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)
Not yet recruiting
- Breast Cancer
- +3 more
- (no location specified)
Aug 4, 2023
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with
Not yet recruiting
- Breast Cancer
- +4 more
- Ovarian function suppression with endocrine treatments
-
Seoul, Korea, Korea, Republic ofGangnam Severance Hospital
Dec 18, 2022
Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,
Recruiting
- Premenopausal Breast Cancer
- +2 more
- Goserelin
- +3 more
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Feb 7, 2023
Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian
Not yet recruiting
- Hormone-receptor-positive Breast Cancer
- +3 more
- Aromatase inhibitor
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023
Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)
Recruiting
- Premenopausal Breast Cancer
- Hormone Receptor-positive Breast Cancer
- Tamoxifen Oral Product
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 14, 2022
Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)
Completed
- Breast Cancer
- OFS + Anastrozole
- OFS + Exemestane
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
Ovarian Reserve in Premenopausal Breast Cancer
Terminated
- Premenopausal Breast Cancer
- Breast Cancer
-
Dublin, Dublin 18, Ireland
- +9 more
Jan 14, 2022
Assessment of Brain Cognitive Impairment in Breast Cancer
Recruiting
- Breast Cancer
- +2 more
- PET/MRI, psychobehavioral tests and questionnaires, serum biomarkers and stool sample
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Jul 12, 2022
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Breast Cancer Trial in Visakhapatnam (Goserelin acetate 3.6 mg Injection, ZOLADEX® 3.6mg Injection)
Recruiting
- Breast Cancer
- Goserelin acetate 3.6 mg Injection
- ZOLADEX® 3.6mg Injection
-
Visakhapatnam, Andhra Pradesh, IndiaMahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022
Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)
Not yet recruiting
- Breast Cancer
- Breast Cancer, Early-Onset
- (no location specified)
Jan 18, 2023
Induced Alopecia Among Postmenopausal and Premenopausal Female
Recruiting
- Breast Carcinoma
- Electronic Health Record Review
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Ovarian Reserve in Premenopausal Early-stage Breast Cancer or
Recruiting
- Breast Cancer
- Blood draw and questionnaires
-
Basking Ridge, New Jersey
- +7 more
Jan 19, 2023
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in
Recruiting
- Breast Cancer Female
- lifestyle
-
Santiago, Independencia, Chile
- +7 more
Aug 30, 2021
To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast
Active, not recruiting
- To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years
- OFS continues to use group after 5 years
- Immunohistochemical detection of HR status
-
Wuhan, Hubei, ChinaWu Xinhong
Sep 17, 2023
Quality of Life and Hormone Levels in Premenopausal Early Breast
Recruiting
- Early-stage Breast Cancer
-
Bologna, Italy
- +17 more
Jan 31, 2023
Premenopausal Breast Cancer Trial in Taipei (Pembrolizumab/ Exemestane/ Leuprolide)
Recruiting
- Premenopausal Breast Cancer
- Pembrolizumab/ Exemestane/ Leuprolide
-
Taipei, TaiwanNational Taiwan University Hospital
May 6, 2021
Female Breast Cancer Trial in Germany
Recruiting
- Female Breast Cancer
-
Moenchengladbach, NRW, Germany
- +4 more
Mar 30, 2023
Towards Early Detection of Breast Cancer in High Risk Population
Not yet recruiting
- Breast Cancer
- MRI scan
- Blood test
-
Aberdeen, Aberdeenshire, United KingdomAberdeen Biomedical Imaging Centre
Feb 24, 2022
Improve Sexual Health, Improve Vulvovaginal Health Trial in United States (questionnaires, moisturizers)
Recruiting
- Improve Sexual Health
- Improve Vulvovaginal Health
- questionnaires
- moisturizers
-
Basking Ridge, New Jersey
- +6 more
Jun 9, 2023